The Washington Post has published a letter from the vice chair of the American Thoracic Society’s Tobacco Action Committee attacking the FDA for its more neutral position on new nicotine technologies, accusing the agency of promoting a switch from one addiction to another, underlining an ideological trope that lies at the heart of much of the response from many national and international so-called ‘health’ agencies.Read More
In March the GFN team organised a series of three dialogues in the UK to explore ‘How safe is vaping? Media coverage, dilemmas and solutions in work and social spaces’ These, each hosted by local partners, took place in Leicester, Liverpool and Glasgow.
The format was for a panel of leading thinkers and advocates to give short introductions, followed by a discussion involving the audience. Each event was designed to last for about 2 hours.Read More